Venlafaxine discontinuation syndrome and suicidal ideation: A case series [5]

Journal of Clinical Psychopharmacology

Volumn 27, Issue 1, 2007, Pages 94-95

  Stone, Timothy E ^a   Swanson, Charles ^b   Feldman, Marc D ^c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALABAMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLONAZEPAM; VENLAFAXINE;

ADULT; ANXIETY; CASE REPORT; CLINICAL FEATURE; DRUG DOSE TITRATION; DRUG EFFECT; FATIGUE; FEMALE; GENERALIZED ANXIETY DISORDER; HUMAN; LETTER; LOW DRUG DOSE; MAJOR DEPRESSION; MALE; MYALGIA; PRIORITY JOURNAL; RHINORRHEA; SUICIDAL IDEATION; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CYCLOHEXANOLS; FEMALE; HUMANS; MALE; MIDDLE AGED; SUBSTANCE WITHDRAWAL SYNDROME; SUICIDE, ATTEMPTED;

EID: 33846233341     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31802e84b9     Document Type: Letter

References (3)

1. Anderson H, Kristiansen ES. Tofranil treatment of endogenous depressions. Acta Psychiatr Scand. 1959;34:387-397.
2. Ladner M. Benzodiazepine withdrawal states. In: Trimble MR, ed. Benzodiazepines Divided. New York: John Wiley; 1983:17-31.
3. Dilsaver SC, Greden JF, Snider RM. Antidepressant withdrawal syndromes: phenomenology and physiopathology. Int Clin Psychopharmacol. 1987;2:1-19.